Citurgia Biochemicals board to consider Q4FY26 results on May 30
Citurgia Biochemicals Limited will hold a board meeting on May 30, 2026, to approve audited financial results for the quarter and year ended March 31, 2026. The trading window for insiders remains closed and will reopen 48 hours after the results are announced.
*this image is generated using AI for illustrative purposes only.
Citurgia Biochemicals Limited has announced that its board of directors will meet on Saturday, May 30, 2026. The primary agenda of the meeting is to consider and approve the audited financial results for the quarter and year ended March 31, 2026.
The meeting is being convened pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In addition to the financial results, the board will also consider any other business as per the agenda.
Trading Window Closure
The company has informed the exchanges that the trading window for dealing in the company's equity shares was closed earlier. The closure affects the company's directors, officers, designated employees, and other connected persons.
The trading window initially closed on April 1, 2026. It will remain shut until 48 hours after the financial results are declared to the stock exchanges.
Meeting Details
The following table summarizes the key details regarding the upcoming board meeting:
| Event | Details |
|---|---|
| Company Name | Citurgia Biochemicals Limited |
| Meeting Date | May 30, 2026 |
| Purpose | Consider and approve audited financial results for Q4 and FY ended March 31, 2026 |
| Trading Window Closure | From April 1, 2026; opens 48 hours post-result declaration |
How have Citurgia Biochemicals' revenue and profit margins trended over the past few quarters, and what growth trajectory might the FY2026 annual results reveal?
Will the board consider announcing a dividend or any capital allocation changes alongside the Q4 FY2026 financial results approval?
How might Citurgia Biochemicals' FY2026 performance compare to peers in the biochemicals sector amid evolving raw material costs and demand dynamics?
20
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
